MUMBAI, India, Oct. 5 -- Intellectual Property India has published a patent application (202618109492 A) filed by Regeneron Pharmaceuticals, Inc. on September 11, 2026, for Human Antibodies To Ebola Virus Glycoprotein.
Inventors include Kyratsous, Christos; Olson, William; Mason, Peter; and Stahl, Neil.
The application for the patent was published on October 02, 2026, under issue no. 40/2026.
Abstract: ABSTRACT HUMAN ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN The present invention provides monoclonal antibodies, or antigen-binding 5 fragments thereof, that bind to Ebola virus glycoproteins, pharmaceutical compositions comprising the antibodies and methods of use. The antibodies of the invention are useful for inhibiting or neutralizing Ebola...